1. Bruera E, Miller MJ, Macmillan K, Kuehn N. Neuropsychological effects of
methylphenidate in patients receiving a continuous infusion of narcotics for cancer pain …

Evaluates the effectiveness of end-of-life care. Part 1 contains the front matter, Summary,
and Chapters 1-2. Part 2 contains Chapter 3 (sub-chapters AC). Part 3 contains Chapter 3 …

PAGE 32/MAY 10, 2003 cy through the Web site, but those whose cases are selected for
posting are contacted so they can receive an honorarium. An example of an M&M case is …

In February 1998, an 85-year-old man in severe pain came to the emergency room of a
California hospital. Two 5-mg doses of morphine provided relief and the patient was …

Ann Mullens' account of the initiative by the College of Physicians and Surgeons of British
Columbia to expand its methadone program clearly illustrates the need for better facilities for …

Dying To Access Methadone | Health Affairs For Authors Products & Access Free
Newsletters Subscribe Renew Cart Login Institutional Access Health Affairs Logo Enter topic …

EIDE benefit Mr. White. Should she pro-vide every treatment that could bene-fit him? Or
would she be justified in with holding a potentially beneficial but costly treatment for an …

Introduction: Methylphenidate (MP) is often recommended for symptom control in advanced
cancer. Little is known about its side effects in frail adults. Objectives: To evaluate MP …

Carmen R. Green, MD, associate professor of anesthesiology and health management and
policy at the University of Michigan Schools of Medicine and Public Health in Ann …

Mr. Chairman, members of the Committee: Thank you for inviting me to testify before you
today. Allow me to briefly introduce myself, and then tell you how my experience relates to …